Silence Therapeutics PLC (SLN) Live Share Price, Invest From India

Silence Therapeutics PLC Stock Performance

as on May 8, 2026 at 2:15 pm IST

Day's Low
Day's High
$6.68
Day's Price Range
$7.18
$6.95
3.88%
Downside
3.31%
Upside
52 Week's Low
52 Week's High
$3.54
52-Week Price Range
$8.40
$6.95
49.14%
Downside
20.86%
Upside

Silence Therapeutics PLC share price movements today

Previous Close: $7.36
Open: $7.18
Volume: 360.7K
Day's Low - High: $6.68 - $7.18
52 Week Low - High: $3.54 - $8.40

Silence Therapeutics PLC Historical Returns

1 Month Return: + 31.43 %
3 Month Return: + 54.95 %
1 Year Return: + 98.92 %
3 Year Return: + 15.91 %
5 Year Return: 0 %

Silence Therapeutics PLC Stock Fundamentals & Key Indicators

Check Silence Therapeutics PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$337.3M

EPS (TTM)

-0.795

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-81.7M

Revenue (TTM)

559.0K

Profit Margin

0.00%

Return On Equity TTM

-90.27%

Silence Therapeutics PLC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silence Therapeutics PLC with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Silence Therapeutics PLC	BUY	$337.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Stock Returns calculator for Silence Therapeutics PLC Stock including INR - Dollar returns

The Silence Therapeutics PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Silence Therapeutics PLC investment value today

Current value as on today

₹2,08,942

Returns

₹1,08,942

(+108.94%)

Returns from Silence Therapeutics PLC Stock

₹87,838 (+87.84%)

Dollar Impact

₹21,104 (+21.1%)

Analyst Recommendation on Silence Therapeutics PLC Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Silence Therapeutics PLC. Average target price of $32.8

Silence Therapeutics PLC Share Price Target

Get share price movements and forecasts by analysts on Silence Therapeutics PLC.

What analysts predicted

78.81%UPSIDE

Target Price

$32.8

Current Price

$6.95

Analyzed by

3 Analysts

Target

$32.80

Silence Therapeutics PLC target price $32.8, a slight upside of 78.81% compared to current price of $6.95. According to 3 analysts rating.

Silence Therapeutics PLC Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	3	2	19	0	1	24	0	0	0	0
Gross Profit	1	0	16	-2	-2	22	0	0	0	0
Operating Income	-12	-13	-5	-18	-22	-3	-28	-23	-26	-12
EBITDA	-10	-14	-2	-17	-21	7	-28	-22	-20	-12
Interest Expense	0	0	0	0	8	11	11	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-14	-2	-17	-30	23	-28	-27	-20	-11
Income Tax Expense	-2	0	0	-1	-3	9	9	0	0	0
Net Income	-10	-18	-2	-19	-35	14	-28	-27	-20	-11
Net Profit Margin	-294.85%	-686.61%	-14.73%	-2602.34%	-2365.32%	58.26%	-20091.55%	-12211.61%	-13181.13%	-34617.65%

Silence Therapeutics PLC Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	-	0	7	16	26	32	43	0
Gross Profit	-9	-10	-12	0	2	6	9	19	31	0
Operating Income	-11	-14	-20	-22	-35	-45	-61	-49	-63	-82
EBITDA	-11	-3	-20	-22	-35	-45	-60	-49	-48	-89
Interest Expense	1	0	0	0	0	0	0	0	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-3	-20	-22	-36	-45	-49	-50	-44	-88
Income Tax Expense	-1	-2	-2	-3	-3	-6	0	-7	0	0
Net Income	-10	-2	-23	-25	-43	-52	-61	-54	-45	-88
Net Profit Margin	-1096.10%	-10112.50%	0.00%	-8025.41%	-594.03%	-317.44%	-232.44%	-170.51%	-104.74%	-15851.88%

Silence Therapeutics PLC Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-14	-2	-19	-41	22	-22	-27	-20	-82
Operating Cash Flow	-11	-9	-5	-19	-22	-12	-21	-10	-17
Investing Cash Flow	0	-49	0	-28	49	-44	-1	51	-53
Financing Cash Flow	9	133	1	5	1	0	0	-	0
Change in Cash	-4	73	-4	-47	59	-56	-23	40	-70

Silence Therapeutics PLC Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-20	-22	-36	-61	-50	-50	-36	-88
Operating Cash Flow	-9	-16	1	-10	9	-57	-39	-67	-46
Investing Cash Flow	13	-4	-15	9	11	-20	16	-21	-35
Financing Cash Flow	0	0	5	15	41	52	25	142	0
Change in Cash	3	-21	-7	13	62	-33	0	52	-81

Global Institutional Holdings in Silence Therapeutics PLC

Funds	Holdings
Ishara Investments LP	0.51%
Redmile Group, LLC	4.58%
SG Americas Securities, LLC	0.54%
M28 Capital Management LP	0.39%
Nantahala Capital Management, LLC	3.27%

See all

Insights on Silence Therapeutics PLC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SLN has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, SLN stock has moved up by 54.9%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -28.53M → -11.77M (in $), with an average increase of 37.6% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.4% return, outperforming this stock by 9.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 224.0K → 34.0K (in $), with an average decrease of 53.8% per quarter

About Silence Therapeutics PLC

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.

Organisation	Silence Therapeutics PLC
Headquarters	12 Hammersmith Grove, London, United Kingdom, W6 7AP
Industry	Biotechnology
CEO	Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
E-voting on shares	Click here to vote

Key Management of Silence Therapeutics PLC

Name	Title
Mr. Curtis Rambaran M.D.	Chief Medical Officer
Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D	Interim CEO & Chairman of the Board
Ms. Rhonda L. Hellums	Executive VP, CFO, Secretary & Executive Director
Dr. Steven J. Romano M.D.	Executive VP and Chief Research & Development Officer
Dr. Marie Wikstrom Lindholm Ph.D.	Chief Scientific Officer
Ms. Gem Gokmen Hopkins	Head of IR & Corporate Communications
Mr. Jaimin B. Shah	SVP & General Counsel
Mr. J.P. Gabriel	Chief Technical Operations Officer

FAQs

What is Silence Therapeutics PLC share price today?

Silence Therapeutics PLC share price today is $6.95 as on May 8, 2026 at 8:45 am IST at the close of the market. Silence Therapeutics PLC share today touched a day high of $7.18 and a low of $6.68.

What is the 52 week high and 52 week low for Silence Therapeutics PLC share?

Silence Therapeutics PLC share touched a 52 week high of $8.4 on April 23, 2026 and a 52 week low of $3.54 on May 8, 2025. Silence Therapeutics PLC stock price today i.e. May 8, 2026 at 8:45 am IST is closed at $6.95,which is 17.26% down from its 52 week high and 96.61% up from its 52 week low.

What is Silence Therapeutics PLC's market capitalisation today?

Silence Therapeutics PLC market capitalisation is $0.00T as on May 8, 2026 at 8:45 am IST.

How to invest in Silence Therapeutics PLC Stock (SLN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Silence Therapeutics PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silence Therapeutics PLC Shares that will get you 0.2158 shares as per Silence Therapeutics PLC share price of $6.95 per share as on May 8, 2026 at 8:45 am IST.

What is the minimum amount required to buy Silence Therapeutics PLC Stock (SLN) from India?

Indian investors can start investing in Silence Therapeutics PLC (SLN) shares with as little as ₹94.24 or $1 (as of May 8, 2026 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Silence Therapeutics PLC stock (as per the Rupee-Dollar exchange rate as on May 8, 2026 at 12:40 pm IST). Based on Silence Therapeutics PLC share’s latest price of $6.95 as on May 8, 2026 at 8:45 am IST, you will get 1.4388 shares of Silence Therapeutics PLC. Learn more about fractional shares .